ANI Pharmaceuticals (ANIP)

[Just the facts maam]

In ANIP's S-8 filing they amended the 2022 Stock Incentive plan registering 1.61 million shares allowing them to issue up to 6.51 million shares to employees, a 32.86 % increase over the 4.9 million shares authorized to be issued under the plan in their 2023 amendment to the 2022 Stock Incentive plan. In 2023, they increased the share authorized to be issued by 750,000 going from the 4.15 million shares authorized in the 2022 plan to 4.9 million, an 18.07 % increase over 2022.

Seems like a big jump. It makes me wonder if ANIP is working on another merger, where part of the inducement is an award of shares similar to the deal with Novitium.